Bios_n_Techs Profile
Bios_n_Techs

@Bios_n_Techs

Followers
10K
Following
39K
Media
95
Statuses
35K

Investor with bios & tech focus. Tweets are my opinions only and not investment advice. May have positions short or long term on stocks I tweet.

United States
Joined August 2012
Don't wanna be here? Send us removal request.
@niccruzpatane
Nic Cruz Patane
16 hours
Ron Baron on CNBC this morning on @elonmusk: โ€œYou know, when you think about what he's doing, you talk about the pay package, and this is not like Rockefeller or like Carnegie or like Mellon or like Morgan, Ford, the great industrials who built this nation. This guy is like Da
85
479
4K
@semodough
dough
17 hours
$NVDA MS โฌ†๏ธPT 220 acceleration. expect something of a breakout quarter vs. recent trends. industry checks are showing material acceleration, as NVIDIA has fully resolved earlier issues with the racks, and demand has continued to surge. Growth bottlenecks are less on the NVIDIA
@AIStockSavvy
Hardik Shah
20 hours
$NVDA | ๐๐•๐ˆ๐ƒ๐ˆ๐€ (NVDA): KeyBanc reiterates ๐Ž๐ฏ๐ž๐ซ๐ฐ๐ž๐ข๐ ๐ก๐ญ, ๐๐“ ๐š๐ญ $๐Ÿ๐Ÿ“๐ŸŽ โ€” sees ๐†๐๐Ÿ‘๐ŸŽ๐ŸŽ ๐ซ๐š๐œ๐ค ๐ซ๐ž๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐š๐ง๐ ๐‡๐จ๐ฉ๐ฉ๐ž๐ซ ๐ฌ๐ก๐ข๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ฎ๐ฉ๐ฌ๐ข๐๐ž Analyst expects strong F3Q results and higher F4Q guide as GB300 and Hopper
0
3
7
@Bios_n_Techs
Bios_n_Techs
3 days
$OSCR Added. Likely the worst scenario is baked in with this pullback.
0
0
1
@adamfeuerstein
Adam Feuerstein โœก๏ธ
3 days
Rick Pazdur moving over to take the reins of CDER is a VERY BIG DEAL for the FDA. It may also be the trigger for more change.
13
18
164
@DeItaone
*Walter Bloomberg
3 days
AMD CEO LISA SU: AMD SEES DATA CENTER TOTAL MARKET WILL GROW TO $1 TRILLION BY 2030
35
65
601
@semodough
dough
4 days
Come on ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡บ๐Ÿ‡ธ weโ€™re better then this - Also salute all veterans past and present thank you for your services on #veteranasday ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡บ๐Ÿ‡ธ
@DeItaone
*Walter Bloomberg
4 days
AIR TRAFFIC CONTROLLERS MISS SECOND FULL PAYCHECK Air traffic controllers will miss their second full paycheck on Tuesday due to the ongoing shutdown. Many are struggling financially, with staffing shortages reported at 18 facilities. Federal law requires back pay once the
1
2
15
@ArnieB54331218
Arnie B
4 days
@ScottJenningsKY And now Americans will lose their healthcare, or their premiums will be out of reach. If you have pre-existing medical conditions no more healthcare and these maga morons will watch you die for their party.
4
3
13
@PharmDabbler
PHARM.Dabbler
5 days
BOOM! ๐Ÿซก
0
1
8
@semodough
dough
7 days
$BBIO first report of clinical benefit of this magnitude observed in this high-risk population with significant unmet need - better drug then $PFE $ALNY ๐Ÿ‘๐Ÿคทโ€โ™‚๏ธ
@semodough
dough
7 days
$BBIO 59% risk reduction in ACM in the ATTR-CM variant population at Month 42 (p=0.032) compared to patients initially randomized to placebo in the ATTRibute-CM study โ€ข69% risk reduction in ACM/ first CVH through Month 30 compared to placebo (p=0.016) and a 69% risk reduction in
0
6
27
@Bios_n_Techs
Bios_n_Techs
6 days
#jpm is a house of crooks. Let this be a lesson for retails. Unbelievable corruption by downgrading only to load cheaper. Crime indeed.
@TheTechInvest
The Tech Investor
7 days
๐Ÿšจ Loading up on a stock you downgraded is a crime that is no different to insider trading and should be treated as such. $IREN is expected to generate $4 to $5B in revenue in 2026 compared to $501M in 2025. Yet, JP Morgan is practicing FUD against $IREN in the most bizarre
1
1
4
@TheTechInvest
The Tech Investor
7 days
๐Ÿšจ Loading up on a stock you downgraded is a crime that is no different to insider trading and should be treated as such. $IREN is expected to generate $4 to $5B in revenue in 2026 compared to $501M in 2025. Yet, JP Morgan is practicing FUD against $IREN in the most bizarre
@TheTechInvest
The Tech Investor
7 days
๐ŸšจBREAKING: JP MORGAN INCREASES ITS $IREN STAKE BY 2646% OWNING 645,741 SHARES AS OF Q3 FILING.
29
54
575
@BioStocks
Bio Stocksโ„ข
7 days
$PFE will acquire $MTSR for up to $86.25/share - $65.60/share in cash plus a CVR for up to $20.65/share in cash. $NVO $VKTX
6
7
35
@TheTechInvest
The Tech Investor
8 days
๐ŸšจBREAKING๐Ÿšจ $IREN CEO DAN ROBERTS โ€œTHERE IS APPETITE FROM A NUMBER OF PARTIES IN DISCUSSING CLOUD AND OTHER SERVICES WELL ABOVE 200MW.โ€ ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ๐Ÿ”ฅ $MSFT deal is just the appetizers!
17
59
839
Hereโ€™s what I think will happen in NYC under Mahdami. The free buses and government grocery stores wonโ€™t happen, they never do. They sound good during campaigns, but collapse under basic math. You canโ€™t run a city on ideas that cost billions and produce no revenue. The only way
2K
9K
57K
@Bios_n_Techs
Bios_n_Techs
9 days
Great timing with holidays coming up fast. Still wonโ€™t be serious enough for the folks at Congress to get a deal done.
@BioStocks
Bio Stocksโ„ข
9 days
FAA to cut flights by 10% at 40 major airports due to government #shutdown
0
0
1
@Beth_Kindig
Beth Kindig
9 days
Amazon $AMZN CEO Andy Jassy: โ€œWeโ€™re now double the power capacity that AWS was in 2022, and we're on track to double again by 2027. โ€ฆ You're going to see us continue to be very aggressive in investing in capacity because we see the demand. As fast as we're adding capacity
13
46
407
@Pharmdca
Pharmdca
9 days
If $MTSR is acquired by $NVO whatโ€™s $PFE gonna do Regardless of your position or opinion I believe $VKTX remains the only viable option left in the obesity franchise to be acquired or partnered with keeping in mind how far they are ahead in the obesity development $GPCR could
9
5
56
@Bios_n_Techs
Bios_n_Techs
9 days
$DUOL Over reaction post ER sell off. Added in low 210โ€™s. Stock shouldnโ€™t be down so much.
@Top_Bloomberg
Bloomberg Breaking News
9 days
*DUOLINGO 3Q REV. $271.7M, EST. $260.3M Daily active users 50.5 million, +36% y/y, estimate 50.73 million Paid subscribers 11.5 million, +34% y/y, estimate 11.44 million Adjusted Ebitda $80.0 million, +68% y/y, estimate $72.2 million $DUOL
0
0
0
@semodough
dough
9 days
$CYTK Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on Track Ex-U.S. Regulatory Reviews of Aficamten Ongoing in China and E.U. ~$1.25 Billion in Cash, Cash
ir.cytokinetics.com
Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on Track Ex-U.S. Regulatory Reviews of Aficamten Ongoing in China and E.U....
0
6
12